Neuronascent discovers and develops therapies for depression, Alzheimer's, Parkinson's, and other neurodegenerative diseases based on the science of neurogenesis that:

• Reduce the loss of neurons
 • Restore and replace damaged neurons
• Promote the formation of new neurons
• Reverse cognitive loss

 

 

05.18.10 - CSO of Neuronascent delivered a presentation entitled "Regeneration in Neurodegeneratve Disorders through Neurogenesis" at 2nd Annual Drug Development for Neurodegenerative Diseases conference in Boston.

11.03.09 - Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using NeuroNascent's Neurogenisis Platform

09.11.09 - Neuronascent, Inc. and ChemDiv, Inc. Announce R&D Collaboration for Development of a Novel CNS Neurogenic Drug Candidate

[home] [about us] [technology] [R&D programs] [news & events] [contact us]
NeuroNascent, Inc. - All Rights Reserved - site by TeraMark, LLC